Nuvita İlaç Ranks Among Turkey's Top 250 Companies for R&D Investment

Nuvita İlaç, which took over Orzaks' production capacity, has entered the ranks of Turkey's top 250 companies in R&D investment performance. The company has increased R&D spending tenfold over the past four years, pushing it above TRY 100 million.

The results of the 2024 Turkey R&D 250 Research, conducted annually by business and economics portal Turkishtime, have been announced. On the list prepared from the statements of the top 500 companies in Turkey's export rankings, R&D centers registered with the Ministry of Industry and Technology, and companies sharing R&D data on the Public Disclosure Platform, Nuvita İlaç, the production facility of Orzaks, was among the top 250 companies.

10-Fold Increase in R&D Investment
Nuvita İlaç increases its scientific R&D efforts every year through its quality-focused production approach and structure compliant with international standards. Since 2021, the company has increased R&D spending tenfold, surpassing TRY 100 million.

Currently, 38 projects are being conducted at the R&D Center, while 9 public projects have been completed successfully to date. Currently, 2 public projects are ongoing. Additionally, Nuvita İlaç submitted a total of 11 patent applications, 2 in 2023 and 9 in 2024.

"We are developing innovative solutions that will add value to human health"
Nuvita İlaç R&D Director Akif Kavak evaluated the success achieved and made the following remarks:

"With our investments in R&D and innovation, we are supporting not only our company's growth but also our country's development goals. By converting scientific knowledge into economic value, we contribute to both academia and the private sector. While creating lasting value for the literature and sector through strategic raw material production and our innovative projects, we will continue to develop innovative solutions that will benefit human health."

About Turkey R&D 250 Research
The Turkey R&D 250 Research, prepared by Turkishtime since 2013, reveals Turkey's companies with the highest R&D investments. The study is conducted with the participation of the top 500 companies in the export rankings, R&D centers approved by the Ministry of Industry and Technology, and companies disclosing R&D data on the Public Disclosure Platform.

The research results are distributed to 6,500 VIP addresses, including national and international media as well as the Presidency, ministries, governorates, TÜBİTAK, YÖK, TİM, TUSIAD, and finance sector executives. Additionally, it is distributed digitally to 40,000 decision-makers domestically and 3,000 internationally.